Guofeng Cheng

4.1k total citations · 1 hit paper
35 papers, 3.0k citations indexed

About

Guofeng Cheng is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Guofeng Cheng has authored 35 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 25 papers in Epidemiology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Guofeng Cheng's work include Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (23 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Guofeng Cheng is often cited by papers focused on Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (23 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Guofeng Cheng collaborates with scholars based in United States, China and United Kingdom. Guofeng Cheng's co-authors include Francis V. Chisari, Jin Zhong, Pablo Gastaminza, Stefan Wieland, Dennis R. Burton, Takaji Wakita, Takanobu Kato, Sharookh B. Kapadia, Susan L. Uprichard and Wei Liao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Guofeng Cheng

35 papers receiving 3.0k citations

Hit Papers

Robust hepatitis C virus infection in vitro 2005 2026 2012 2019 2005 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Robust hepatitis C virus infection in vitro
    2005 1.4k citations Jin Zhong, Pablo Gastaminza et al. Proceedings of the National Academy of Sciences profile →

Peers

Guofeng Cheng
Keril J. Blight United States
T. Jake Liang United States
Margarita Zayas Germany
Zhen–Yong Keck United States
Nicole Appel Germany
Jérôme Gouttenoire Switzerland
Hans Christian Spangenberg Germany
Cinzia Traboni Italy
K.‐H. Heermann Germany
Yusuke Miyanari Japan
Keril J. Blight United States
Guofeng Cheng
Citations per year, relative to Guofeng Cheng Guofeng Cheng (= 1×) peers Keril J. Blight

Countries citing papers authored by Guofeng Cheng

Since Specialization
Citations

This map shows the geographic impact of Guofeng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Cheng more than expected).

Fields of papers citing papers by Guofeng Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guofeng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Cheng. The network helps show where Guofeng Cheng may publish in the future.

Co-authorship network of co-authors of Guofeng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Guofeng Cheng. A scholar is included among the top collaborators of Guofeng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guofeng Cheng. Guofeng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Mei, Maura Dandri, Guofeng Cheng, et al.. (2024). Rapid and Reliable Protein-Free HBV DNA Extraction and Sensitive Branched DNA Southern Blot Assay. Methods in molecular biology. 2837. 113–124. 1 indexed citations
2.
Lake, April D., Joseph C. Arezzo, Ricardo Ramírez, et al.. (2022). Neurotoxicity of an Hepatitis B Virus (HBV) Transcript Inhibitor in 13-Week Rat and Monkey Studies. Toxicological Sciences. 186(2). 298–308. 8 indexed citations
3.
Ramírez, Ricardo, Nicholas van Buuren, Cameron M. Soulette, et al.. (2021). Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines. Journal of Virology. 95(19). e0029921–e0029921. 30 indexed citations
4.
Watanabe, Noriyuki, Tomoko Date, Hideki Aizaki, et al.. (2019). Establishment of infectious genotype 4 cell culture-derived hepatitis C virus. Journal of General Virology. 101(2). 188–197. 4 indexed citations
5.
Camus, Grégory, Simin Xu, Bin Han, et al.. (2017). Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems. Virology. 514. 134–141. 11 indexed citations
6.
Niu, Congrong, Christine M. Livingston, Li Li, et al.. (2017). The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection. PLoS ONE. 12(1). e0169648–e0169648. 114 indexed citations
7.
Cheng, Guofeng, Tian Yang, Brian Doehle, et al.. (2016). In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir. Antimicrobial Agents and Chemotherapy. 60(3). 1847–1853. 50 indexed citations
8.
Kwon, Hyock Joo, Weimei Xing, Anita Niedziela‐Majka, et al.. (2015). Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent. PLoS ONE. 10(4). e0122844–e0122844. 29 indexed citations
9.
Mei, Yu, Amoreena C. Corsa, Simin Xu, et al.. (2013). In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons. Antiviral Research. 100(2). 439–445. 17 indexed citations
10.
Peng, Betty, Yu Mei, Simin Xu, et al.. (2012). Development of Robust Hepatitis C Virus Genotype 4 Subgenomic Replicons. Gastroenterology. 144(1). 59–61.e6. 30 indexed citations
11.
Qi, Fuzhen, et al.. (2012). Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World Journal of Surgical Oncology. 10(1). 163–163. 37 indexed citations
12.
Lawitz, Eric, Daniel Gruener, John M. Hill, et al.. (2012). A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C. Journal of Hepatology. 57(1). 24–31. 120 indexed citations
13.
Cheng, Guofeng, Rudolf K. Beran, Huiling Yang, et al.. (2011). An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture. Virology. 422(2). 224–234. 10 indexed citations
14.
Montero, Ana, Pablo Gastaminza, Mansun Law, et al.. (2011). Self-Assembling Peptide Nanotubes with Antiviral Activity against Hepatitis C Virus. Chemistry & Biology. 18(11). 1453–1462. 46 indexed citations
15.
Yang, Hai, Cheng Yong Yang, Gerry Rhodes, et al.. (2011). 779 PRECLINICAL CHARACTERIZATION OF THE NOVEL HCV NS3 PROTEASE INHIBITOR GS-9256. Journal of Hepatology. 54. S313–S313. 2 indexed citations
16.
Fenaux, Martijn, Guofeng Cheng, Eric Mabery, et al.. (2011). 1205 GS-6620, A NOVEL ANTI-HEPATITIS C VIRUS NUCLEOTIDE PRODRUG, HAS A HIGH BARRIER TO RESISTANCE IN VITRO. Journal of Hepatology. 54. S476–S476. 3 indexed citations
17.
Zhong, Jin, Pablo Gastaminza, Josan Chung, et al.. (2006). Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost. Journal of Virology. 80(22). 11082–11093. 211 indexed citations
18.
Cheng, Guofeng, Jin Zhong, & Francis V. Chisari. (2006). Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proceedings of the National Academy of Sciences. 103(22). 8499–8504. 97 indexed citations
19.
Zhong, Jin, Pablo Gastaminza, Guofeng Cheng, et al.. (2005). Robust hepatitis C virus infection in vitro. Proceedings of the National Academy of Sciences. 102(26). 9294–9299. 1430 indexed citations breakdown →
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keril J. Blight Breakdown of academic impact, for papers by T. Jake Liang Breakdown of academic impact, for papers by Margarita Zayas Breakdown of academic impact, for papers by Zhen–Yong Keck Breakdown of academic impact, for papers by Nicole Appel Breakdown of academic impact, for papers by Jérôme Gouttenoire Breakdown of academic impact, for papers by Hans Christian Spangenberg Breakdown of academic impact, for papers by Cinzia Traboni Breakdown of academic impact, for papers by K.‐H. Heermann Breakdown of academic impact, for papers by Yusuke Miyanari
Rankless by CCL
2026